Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Paclitaxel (liposomal)

EU orphan designation number: EU/3/06/419   
Active ingredient: Paclitaxel (liposomal)
Indication: Treatment of pancreatic cancer
Sponsor: SynCore Biotechnology Europe GmbH
c/o Hogan Lovells International LLP, Karl-Scharnagl-Ring 5, 80539 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/11/2006 Orphan designation EMEA/OD/063/06 (2006)5348 of 31/10/2006
20/06/2016 Transfer of orphan designation EMA/OD/063/06/T/01 (2016)3839 of 16/06/2016